Results 161 to 170 of about 262,476 (307)

Twenty‐Four Month Outcomes From a Real‐World Telehealth Obesity Treatment Clinic Using Obesity Medications

Obesity, EarlyView.
ABSTRACT Objective Antiobesity medications (AOMs) are indicated for long‐term use; however, evidence of their real‐world long‐term efficacy is limited. This study describes clinical outcomes from 18‐ and 24‐month use of AOMs in a telemedicine weight management clinic.
Kathleen R. Ruddiman, Young‐Rock Hong, Jamy Ard, Rebecca Jones, Adam Medcalf, Gary D. Foster, Jamil Alkhaddo, Michelle Cardel   +7 more
wiley   +1 more source

SfE BES 2026: What's new in basic science endocrinology? [PDF]

J Mol Endocrinol
da Silva Xavier G.
europepmc   +2 more sources

Weight Loss With GLP‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective Two glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) (semaglutide and liraglutide) and one dual agonist (tirzepatide) are FDA‐approved for weight loss in adults with obesity without type 2 diabetes mellitus. This systematic review and network meta‐analysis aims to compare the efficacy of these agents against each other.
Michael Lim, Pooja Gokhale, Akwasi Akosah, Lorenzo Villa‐Zapata   +3 more
wiley   +1 more source

Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment

Obesity, EarlyView.
ABSTRACT Objective We sought to determine how the proportion of adults historically receiving obesity interventions would be classified under the recently proposed “pre‐clinical” and “clinical” obesity classifications and the impact of this change on safety and outcomes.
Jason M. Samuels, Emma Holler, Matthew D. Spann, C. Joe Northup, Tarik K. Yuce   +4 more
wiley   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source

Obesity as the Upstream Driver of Inflammation and Insulin Resistance in Hyperuricaemia. [PDF]

Endocrinol Diabetes Metab
Monjur MR.
europepmc   +1 more source

Weight Change Between Pregnancies and Mortality Over 50 Years of Follow‐Up

Obesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the link between postpartum weight retention (PPWR) and long‐term mortality. Methods In this secondary analysis of 8165 women with ≥ 2 pregnancies in the Collaborative Perinatal Project (CPP), U.S., 1959–1966, with vital status follow‐up through 2016, we used interconception weight change (ICWC) and ...
Yajnaseni Chakraborti, Sunni L. Mumford, Edwina H. Yeung, Katherine L. Grantz, Pauline Mendola, James L. Mills, Ellen C. Caniglia, Colleen M. Brensinger, Cuilin Zhang, Enrique F. Schisterman, Stefanie N. Hinkle   +10 more
wiley   +1 more source

Association of Weight Status and Quality of Life Through Childhood and Adolescence: Australian Longitudinal Cohort Analysis

Obesity, EarlyView.
ABSTRACT Objective This study examined the relationship between health‐related quality of life (HRQoL) and weight status across the pediatric life course. Methods We analyzed data from a cohort of 9745 children from the Longitudinal Study of Australian Children, with follow‐up over 14 years.
Alison Hayes, Thomas Lung, Kirsten Howard, Louise Baur, Anagha Killedar   +4 more
wiley   +1 more source

Acute and extremely severe necrotic esophagitis accompanied by hyperglycemic hyperosmolar syndrome in a subject with type 2 diabetes mellitus

Journal of Diabetes Investigation, 2021
Yuichiro Iwamoto, Fuminori Tatsumi, Hayato Isobe, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Hideaki Kaneto   +7 more
doaj   +1 more source

Diabetes Fact Sheet 2025: Special Edition on Diabetes with Obesity and in Pregnancy. [PDF]

Diabetes Metab J
Park SE, Min SH, Kim JH, Lee SH, Jung HN, Moon JH, Han K, Ko SH, Cha BS, Choi SH.   +9 more
europepmc   +1 more source